155 related articles for article (PubMed ID: 32729243)
21. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
22. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype.
van Alfen N; Sinke RJ; Zwarts MJ; Gabreëls-Festen A; Praamstra P; Kremer BP; Horstink MW
Ann Neurol; 2001 Jun; 49(6):805-7. PubMed ID: 11409435
[TBL] [Abstract][Full Text] [Related]
23. Psychiatric disorders, spinocerebellar ataxia type 3 and CAG expansion.
Silva UC; Marques W; Lourenço CM; Hallak JE; Osório FL
J Neurol; 2015 Jul; 262(7):1777-9. PubMed ID: 26067219
[TBL] [Abstract][Full Text] [Related]
24. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
[TBL] [Abstract][Full Text] [Related]
25. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
Jia D; Jiang H; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
[TBL] [Abstract][Full Text] [Related]
26. Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.
Chakraborty A; Tapryal N; Venkova T; Mitra J; Vasquez V; Sarker AH; Duarte-Silva S; Huai W; Ashizawa T; Ghosh G; Maciel P; Sarkar PS; Hegde ML; Chen X; Hazra TK
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8154-8165. PubMed ID: 32205441
[TBL] [Abstract][Full Text] [Related]
27. Teaching NeuroImages: Retinopathy in spinocerebellar ataxia type 3.
Nascimento FA; Ferreira MG; Shiokawa N; Sato MT; Teive HAG
Neurology; 2020 May; 94(21):e2283-e2284. PubMed ID: 32332129
[No Abstract] [Full Text] [Related]
28. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
[TBL] [Abstract][Full Text] [Related]
29. Derivation of spinocerebellar ataxia type 3 human embryonic stem cell line UMICHe001-A/UM134-1.
Moore LR; Keller L; Paulson HL; Smith GD
Stem Cell Res; 2022 Oct; 64():102873. PubMed ID: 35952620
[TBL] [Abstract][Full Text] [Related]
30. [Clinical features and gene mutation analysis in Machado-Joseph disease of spinocerebellar ataxia type 3 in littoral of Zhejiang].
Jin YY; Zeng AP; Cai HB; Wu F; Feng Z; Hong Q; Zhang L; Jiang ZK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):132-4. PubMed ID: 20104758
[TBL] [Abstract][Full Text] [Related]
31. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
[TBL] [Abstract][Full Text] [Related]
32. Age is an important independent modifier of SCA3 phenotype severity.
Jiao S; Wang P; Chen Z; Wang C; Shi Y; Qiu R; Tang B; Jiang H
Neurosci Lett; 2021 Jan; 741():135510. PubMed ID: 33221475
[TBL] [Abstract][Full Text] [Related]
33. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
34. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
[TBL] [Abstract][Full Text] [Related]
35. Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients.
Raposo M; Bettencourt C; Ramos A; Kazachkova N; Vasconcelos J; Kay T; Bruges-Armas J; Lima M
Neuromolecular Med; 2017 Mar; 19(1):41-45. PubMed ID: 27246313
[TBL] [Abstract][Full Text] [Related]
36. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients?
Emmel VE; Alonso I; Jardim LB; Saraiva-Pereira ML; Sequeiros J
Clin Genet; 2011 Jan; 79(1):100-2. PubMed ID: 21143471
[No Abstract] [Full Text] [Related]
37. Homozygote of spinocerebellar Ataxia type 3 correlating with severe phenotype based on analyses of clinical features.
Shang XJ; Xu HL; Yang JS; Chen PP; Lin MT; Qian MZ; Lin HX; Chen XP; Chen YC; Jiang B; Chen YJ; Chen WJ; Wang N; Zhou ZM; Gan SR
J Neurol Sci; 2018 Jul; 390():111-114. PubMed ID: 29801869
[TBL] [Abstract][Full Text] [Related]
38. [Detection and analysis of dynamic variant in a pedigree affected with spinocerebellar ataxia type 3].
Chen C; Zhao X; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1364-1367. PubMed ID: 33306823
[TBL] [Abstract][Full Text] [Related]
39. Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3.
Johnson SL; Blount JR; Libohova K; Ranxhi B; Paulson HL; Tsou WL; Todi SV
Neurobiol Dis; 2019 Dec; 132():104535. PubMed ID: 31310802
[TBL] [Abstract][Full Text] [Related]
40. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China].
Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
